Skip to main content

Advertisement

SpringerLink
Log in

Strategies for living well with hormone-responsive advanced prostate cancer—a qualitative exploration

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Due to recent treatment advances, men are increasingly living longer with advanced prostate cancer (PCa). This study sought to understand men’s experiences of living with and adjusting to advanced hormone-responsive PCa and how this influenced their quality of life (QoL), in order to highlight how support could be optimized.

Methods

Participants were recruited through a UK wide survey—the ‘Life After Prostate Cancer Diagnosis’ study. In-depth telephone interviews were conducted with 24 men (aged 46–77 years) with advanced (stage IV) hormone-responsive PCa diagnosed 18–42 months previously. Thematic analysis was undertaken using a framework approach.

Results

Most participants perceived their QoL to be relatively good, which was influenced by the following factors (enablers to ‘living well’ with PCa): a sense of connectedness to others, engagement in meaningful activities, resources (social, cognitive, financial), ability to manage uncertainty, utilization of adjustment strategies and support, communication and information from health professionals. Barriers to ‘living well’ with PCa were often the converse of these factors. These also included more troublesome PCa-related symptoms and stronger perceptions of loss and restriction.

Conclusions

In our study, men living with advanced hormone-responsive PCa often reported a good QoL. Exploring the influences on QoL in men with advanced PCa indicates how future interventions might improve the QoL of men who are struggling. Further research is required to develop and test interventions that enhance QoL for these men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

The datasets generated and/or analysed in the current study are not available publicly as eligible patients were informed at the time of the survey that their data would be stored securely and confidentially.

References

  1. Cancer Research UK (2018) Prostate cancer incidence statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence#heading-Three. Accessed 12/11/2018 2018

  2. Cancer Research UK (2018) Prostate cancer survival statistics https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/survival#heading-Three. Accessed 12/11/2018 2018

  3. National Institute For Health and Care Excellence (2019) Prostate Cancer: Diagnosis and Management [NG131]. https://www.nice.org.uk/guidance/ng131. Accessed 23rd May 2019

  4. James ND, de Bono JS, Spears MR, Clarke NW, Mason MD, Dearnaley DP, Ritchie AWS, Amos CL, Gilson C, Jones RJ, Matheson D, Millman R, Attard G, Chowdhury S, Cross WR, Gillessen S, Parker CC, Russell JM, Berthold DR, Brawley C, Adab F, Aung S, Birtle AJ, Bowen J, Brock S, Chakraborti P, Ferguson C, Gale J, Gray E, Hingorani M, Hoskin PJ, Lester JF, Malik ZI, McKinna F, McPhail N, Money-Kyrle J, O’Sullivan J, Parikh O, Protheroe A, Robinson A, Srihari NN, Thomas C, Wagstaff J, Wylie J, Zarkar A, Parmar MKB, Sydes MR (2017) Abiraterone for prostate cancer not previously treated with hormone therapy. NEJM 377(4):338–351. https://doi.org/10.1056/NEJMoa1702900

    Article  CAS  PubMed  Google Scholar 

  5. Watson E, Shinkins B, Frith E, Neal D, Hamdy F, Walter F, Weller D, Wilkinson C, Faithfull S, Wolstenholme J, Sooriakumaran P, Kastner C, Campbell C, Neal R, Butcher H, Matthews M, Perera R, Rose P (2016) Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up. BJU Int 117(6B):E10–E19. https://doi.org/10.1111/bju.13122

    Article  PubMed  Google Scholar 

  6. Nead KT, Sinha S, Yang DD, Nguyen PL (2017) Association of androgen deprivation therapy and depression in the treatment of prostate cancer: a systematic review and meta-analysis. Urol Oncol 35(11):664 e661–664 e669. https://doi.org/10.1016/j.urolonc.2017.07.016

    Article  CAS  Google Scholar 

  7. Fang F, Keating NL, Mucci LA, Adami HO, Stampfer MJ, Valdimarsdottir U, Fall K (2010) Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst 102(5):307–314. https://doi.org/10.1093/jnci/djp537

    Article  PubMed  Google Scholar 

  8. van Leeuwen PJ, Schröder FH (2010) Increased risk of suicide after prostate cancer diagnosis. Nat Rev Urol 7:369–370. https://doi.org/10.1038/nrurol.2010.83

    Article  PubMed  Google Scholar 

  9. Gentili C, McClean S, Hackshaw-McGeagh L, Bahl A, Persad R, Harcourt D (2019) Body image issues and attitudes towards exercise amongst men undergoing androgen deprivation therapy (ADT) following diagnosis of prostate cancer. Psychooncology 28:1647–1653. https://doi.org/10.1002/pon.5134

    Article  PubMed  Google Scholar 

  10. Charalambous A, Kouta C (2016) Cancer related fatigue and quality of life in patients with advanced prostate cancer undergoing chemotherapy. Biomed Res Int 2016:11–11. https://doi.org/10.1155/2016/3989286

    Article  CAS  Google Scholar 

  11. Levy A, Cartwright T (2015) Men’s strategies for preserving emotional well-being in advanced prostate cancer: an interpretative phenomenological analysis. Psychol Health 30(10):1164–1182. https://doi.org/10.1080/08870446.2015.1040016

    Article  PubMed  Google Scholar 

  12. Shen MJ, Nelson CJ, Peters E, Slovin SF, Hall SJ, Hall M, Herrera PC, Leventhal EA, Leventhal H, Diefenbach MA (2015) Decision-making processes among prostate cancer survivors with rising PSA levels: results from a qualitative analysis. Med Decis Mak 35(4):477–486. https://doi.org/10.1177/0272989X14558424

    Article  Google Scholar 

  13. Stapleton S, Pattison N (2015) The lived experience of men with advanced cancer in relation to their perceptions of masculinity: a qualitative phenomenological study. J Clin Nurs 24(7–8):1069–1078. https://doi.org/10.1111/jocn.12713

    Article  PubMed  Google Scholar 

  14. Rivas C, Matheson L, Nayoan J, Glaser A, Gavin A, Watson E, Wagland R (Submitted) Men’s transformations following a prostate cancer diagnosis and opportunities for intervention: a metaethnographic study

  15. Grunfeld EA, Halliday A, Martin P, Drudge-Coates L (2011) Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms. Cancer Nurs 35(1):63–69. https://doi.org/10.1097/NCC.0b013e318211fa92

    Article  Google Scholar 

  16. Sartor O, Flood E, Beusterien K, Park J, Webb I, MacLean D, Wong BJO, Mark Lin H (2015) Health-related quality of life in advanced prostate cancer and its treatments: biochemical failure and metastatic disease populations. Clin Genitourin Cancer 13(2):101–112. https://doi.org/10.1016/j.clgc.2014.08.001

    Article  PubMed  Google Scholar 

  17. Lepherd L (2013) Spirituality in men with advanced prostate cancer: "it's a holistic thing . . . it's a package". J Holist Nurs 32(2):89–101; quiz 102-103. https://doi.org/10.1177/0898010113504492

    Article  PubMed  Google Scholar 

  18. Carlander I, Ternestedt BM, Sahlberg-Blom E, Hellstrom I, Sandberg J (2011) Four aspects of self-image close to death at home. Int J Qual Stud Health Well Being 6(2). https://doi.org/10.3402/qhw.v6i2.5931

  19. Lindqvist O, Rasmussen BH, Widmark A (2008) Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases. Eur J Oncol Nurs 12(4):283–290. https://doi.org/10.1016/j.ejon.2008.03.003

    Article  PubMed  Google Scholar 

  20. Lindqvist O, Widmark A, Rasmussen BH (2006) Reclaiming wellness - living with bodily problems, as narrated by men with advanced prostate cancer. Cancer Nurs 29(4):327–337. https://doi.org/10.1097/00002820-200607000-00012

    Article  PubMed  Google Scholar 

  21. Chambers SK, Hyde MK, Laurie K, Legg M, Frydenberg M, Davis ID, Lowe A, Dunn J (2018) Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative study. BMJ Open 8(2):e019917. https://doi.org/10.1136/bmjopen-2017-019917

    Article  PubMed  PubMed Central  Google Scholar 

  22. Downing A, Wright P, Wagland R, Watson E, Kearney T, Mottram R, Allen M, Cairnduff V, McSorley O, Butcher H, Hounsome L, Donnelly C, Selby P, Kind P, Cross W, Catto JW, Huws D, Brewster DH, McNair E, Matheson L, Rivas C, Nayoan J, Horton M, Corner J, Verne J, Gavin A, Glaser AW (2016) Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study. BMJ Open 6(12):e013555. https://doi.org/10.1136/bmjopen-2016-013555

    Article  PubMed  PubMed Central  Google Scholar 

  23. Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349–357. https://doi.org/10.1093/intqhc/mzm042

    Article  PubMed  Google Scholar 

  24. Matheson L, Watson EK, Nayoan J, Wagland R, Glaser A, Gavin A, Wright P, Rivas C (2017) A qualitative metasynthesis exploring the impact of prostate cancer and its management on younger, unpartnered and gay men. Eur J Cancer Care 26(6). https://doi.org/10.1111/ecc.12676

  25. Rivas C, Matheson L, Nayoan J, Glaser A, Gavin A, Wright P, Wagland R, Watson E (2016) Ethnicity and the prostate cancer experience: a qualitative metasynthesis. Psycho-Oncology 25(10):1147–1156. https://doi.org/10.1002/pon.4222

    Article  PubMed  PubMed Central  Google Scholar 

  26. QSR International Pty Ltd (2016) NVivo qualitative data analysis Software: version 11

  27. Gale NK, Heath G, Cameron E, Rashid S, Redwood S (2013) Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 13:117. https://doi.org/10.1186/1471-2288-13-117

    Article  PubMed  PubMed Central  Google Scholar 

  28. Rosenfeld B, Roth AJ, Gandhi S, Penson D (2004) Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psycho-Oncology 13(11):800–807. https://doi.org/10.1002/pon.797

    Article  PubMed  Google Scholar 

  29. Torvinen S, Färkkilä N, Sintonen H, Saarto T, Roine RP, Taari K (2013) Health-related quality of life in prostate cancer. Acta Oncol 52(6):1094–1101. https://doi.org/10.3109/0284186X.2012.760848

    Article  PubMed  Google Scholar 

  30. Wright P, Wilding S, Watson E, Downing A, Selby P, Hounsome L, Wagland R, Brewster DH, Huws D, Butcher H, Mottram R, Kearney T, Allen M, Gavin A, Glaser A (2019) Key factors associated with social distress after prostate cancer: results from the United Kingdom Life after Prostate Cancer diagnosis study. Cancer Epidemiol 60:201–207. https://doi.org/10.1016/j.canep.2019.04.006

    Article  PubMed  Google Scholar 

  31. Wilding S, Downing A, Wright P, Selby P, Watson E, Wagland R, Donnelly DW, Hounsome L, Butcher H, Mason M, Henry A, Gavin A, Glaser AW (2019) Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy. Qual Life Res 28(10):2741–2751. https://doi.org/10.1007/s11136-019-02212-x

    Article  PubMed  PubMed Central  Google Scholar 

  32. Chambers SK, Ng SK, Baade P, Aitken JF, Hyde MK, Wittert G, Frydenberg M, Dunn J (2017) Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer. Psycho-Oncology 26(10):1576–1585. https://doi.org/10.1002/pon.4342

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wilding S, Downing A, Wright P, Selby P, Watson E, Wagland R, Donnelly D, Mason M, Henry A, Gavin A, Glaser AW (In preparation) Cancer-related symptoms, mental well-being and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy

  34. Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E, Wagland R, Kind P, Donnelly D, Butcher H (2018) Quality of life in men living with advanced and localised prostate cancer: a United Kingdom population-wide patient-reported outcome study of 30,000 men. Lancet Oncol

  35. Antonovsky A (1979) Health, stress and coping. Jossey-Bass, San Fransisco

    Google Scholar 

  36. Winger JG, Adams RN, Mosher CE (2016) Relations of meaning in life and sense of coherence to distress in cancer patients: a meta-analysis. Psycho-oncology 25(1):2–10. https://doi.org/10.1002/pon.3798

    Article  PubMed  Google Scholar 

  37. Antonovsky A (1987) Unraveling the mystery of health. How people manage stress and stay well. Jossey-Bass, San Fransisco, London

    Google Scholar 

  38. Mishel MH (1990) Reconceptualization of the uncertainty in illness theory. Image J Nurs Sch 22(4):256–262

    Article  CAS  PubMed  Google Scholar 

  39. Bourke L, Gilbert S, Hooper R, Steed LA, Joshi M, Catto JWF, Saxton JM, Rosario DJ (2014) Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 65(5):865–872. https://doi.org/10.1016/j.eururo.2013.09.040

    Article  PubMed  Google Scholar 

  40. Husk K, Blockley K, Lovell R, Bethel A, Lang I, Byng R, Garside R (2019) What approaches to social prescribing work, for whom, and in what circumstances? A realist review. Health Soc Care Community 28:309–324. https://doi.org/10.1111/hsc.12839

    Article  PubMed  PubMed Central  Google Scholar 

  41. Vehling S, Philipp R (2018) Existential distress and meaning-focused interventions in cancer survivorship. Curr Opin Support Palliat Care 12(1):46–51. https://doi.org/10.1097/spc.0000000000000324

    Article  PubMed  Google Scholar 

  42. Kim SH, Shin DW, Kim SY, Yang HK, Nam E, Jho HJ, Ahn E, Cho BL, Park K, Park J-H (2016) Terminal versus advanced cancer: do the general population and health care professionals share a common language? Cancer Res Treat 48(2):759–767. https://doi.org/10.4143/crt.2015.124

    Article  PubMed  Google Scholar 

  43. Courtenay WH (2000) Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med 50(10):1385–1401

    Article  CAS  PubMed  Google Scholar 

  44. Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ (2011) The supportive care needs of men with advanced prostate cancer. Oncol Nurs Forum 38(2):189–198. https://doi.org/10.1188/11.ONF.189-198

    Article  PubMed  Google Scholar 

  45. Jenkins VA, Fallowfield LJ (2016) No man’s land: information needs and resources of men with metastatic castrate resistant prostate cancer. Support Care Cancer 24(11):4471–4473. https://doi.org/10.1007/s00520-016-3358-0

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank all the men who responded to the survey. We thank the Movember Foundation, in partnership with Prostate Cancer UK, for funding the study. We acknowledge the following people for their contribution to the development, setting up and running of the study: Rebecca Mottram, Majorie Allen, Heather Kinnear, Conan Donnelly, Oonagh McSorley, Victoria Cairnduff, Linda Roberts, Adrian Slater, Picker Institute Europe, the LAPCD User Advisory Group and Clinical and Scientific Advisory Group. This study is based in part on information collected and quality assured by the National Cancer Registration and Analysis Service (part of Public Health England), the Northern Ireland Cancer Registry, the Welsh Cancer Intelligence & Surveillance Unit and the Scottish Cancer Registry (part of the Public Health & Intelligence Unit of NHS National Services Scotland).The work of cancer registries uses data provided by patients and collected by health services as part of their care and support.

Funding

The Life After Prostate Cancer Diagnosis study was funded by the Movember Foundation, in partnership with Prostate Cancer UK, as part of the Prostate Cancer Outcomes programme, grant number BO26/MO.

Author information

Author notes

  1. Jo Nayoan

    Present address: European Centre for Environment and Human Health (ECEHH), University of Exeter, Truro, TR1 3HD, UK

  2. Carol Rivas

    Present address: Department of Social Science, University College London (UCL), London, WC1H 0NR, UK

Authors and Affiliations

  1. Oxford School of Nursing and Midwifery, Oxford Brookes University, Oxford, OX3 0FL, UK

    Lauren Matheson, Jo Brett & Eila Watson

  2. Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK

    Jo Nayoan, Carol Rivas & Richard Wagland

  3. Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds, UK

    Penny Wright & Adam Glaser

  4. LAPCD user advisory group, Leeds, UK

    Hugh Butcher & Paul Jordan

  5. Northern Ireland Cancer Registry, Centre for Public Health, Queen’s University Belfast, Belfast, BT12 6BJ, UK

    Anna Gavin

  6. Leeds Institute of Data Analytics, University of Leeds, Leeds, LS2 9JT, UK

    Adam Glaser

  7. Scool of Medicine, Cardiff University, Cardiff, CF14 2TL, UK

    Malcolm Mason

Authors
  1. Lauren Matheson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jo Nayoan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carol Rivas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jo Brett
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Penny Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hugh Butcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Paul Jordan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Anna Gavin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Adam Glaser
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Malcolm Mason
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Richard Wagland
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Eila Watson
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

EW, RW, PW, AG, AG and HB contributed to the study conception and design. Data collection and analysis were performed by LM, JN, CR, JB, RW and EW. The first draft of the manuscript was written by LM, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Eila Watson.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Newcastle/North Tyneside Research Ethics Committee (15/NE/0036), Health Research Authority Confidentiality Advisory Group (15/CAG/0110), NHS Scotland Public Benefit and Privacy Panel (0516–0364), Northern Ireland Research Ethics Office (16/NI/0073)) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Richard Wagland and Eila Watson are joint last authors.

Electronic supplementary material

ESM 1

(PDF 282 kb)

ESM 2

(PDF 351 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matheson, L., Nayoan, J., Rivas, C. et al. Strategies for living well with hormone-responsive advanced prostate cancer—a qualitative exploration. Support Care Cancer 29, 1317–1325 (2021). https://doi.org/10.1007/s00520-020-05594-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-020-05594-8

Keywords

Search

Navigation